fromBusiness Matters
14 hours agoAstraZeneca to invest $50bn in US amid pressure from Trump administration
AstraZeneca has announced plans to invest $50 billion in the United States by the end of the decade, responding to mounting pressure from the Trump administration for global pharmaceutical firms to shift manufacturing and research operations to American soil.
US politics